Parameter
| Biomarker | β-hCG | Full name | Beta Human Chorionic Gonadotropin | Molecular Type | Glycoprotein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Diagnose, efficacy monitoring |
| Disease | TGCT | Disease Subtypes | / | ||
| Organ | Testis | Test Sample / Technology Platform | Serum (chemiluminescence immunoassay, electrochemiluminescence immunoassay) | ||
| Pathobiological Mechanisms | It is produced by the syncytial trophoblast cells and secreted in the tumor containing components of choriocarcinoma or in the seminoma of syncytial trophoblast giant cells. | ||||
| Clinical Availability Status | Routine clinical application (guideline Standard) | ||||
| Notes and Dynamics | The half-life is 24-36 hours. It can serve as an early indicator of therapeutic response. | ||||